Zekoff v. Janssen Pharmaceuticals Inc et al
Beverly N Zekoff |
Teva Pharmaceuticals USA Inc, Teva Branded Pharmaceutical Products R&D, Janssen Pharmaceuticals Inc and Johnson & Johnson Inc |
2:2020cv01703 |
October 30, 2020 |
US District Court for the Northern District of Alabama |
Karon O Bowdre |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on December 1, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 ORDER GRANTING #6 Unopposed MOTION to Stay and the court hereby STAYS all proceedings in this case until after the JPML decides the motion to transfer, or until January 13, 2021, FINDING AS MOOT #9 MOTION for Extension of Time to File Responsive Pldg to Pltf's Complain. The parties SHALL FILE with the court a Joint Status Report on January 13, 2021 updating the court as to the status of the case and its relationship to the MDL litigation. Signed by Judge Karon O Bowdre on 12/1/2020. (JLC) |
Filing 9 Unopposed MOTION for Extension of Time to File Responsive Pldg to Pltf's Complaint by Teva Branded Pharmaceutical Products R&D, Teva Pharmaceuticals USA Inc. (Walker, Thomas) |
Filing 8 NOTICE of Appearance by Hansel Eli Lightner, II on behalf of Teva Branded Pharmaceutical Products R&D, Teva Pharmaceuticals USA Inc (Lightner, Hansel) |
Filing 7 NOTICE of Appearance by Thomas E Walker on behalf of Teva Branded Pharmaceutical Products R&D, Teva Pharmaceuticals USA Inc (Walker, Thomas) |
Filing 6 Unopposed MOTION to Stay All Proceedings Pending a Decision on MDL Centralization by Janssen Pharmaceuticals Inc, Johnson & Johnson Inc. (Attachments: #1 Exhibit A - Motion to Transfer, #2 Exhibit B - Stay Orders)(Bussian, James) |
Filing 5 SUMMONS Returned Executed by Beverly N Zekoff. Johnson & Johnson Inc served on 11/9/2020, answer due 11/30/2020. (MEB2) |
Filing 4 SUMMONS Returned Executed by Beverly N Zekoff. Janssen Pharmaceuticals Inc served on 11/6/2020, answer due 11/27/2020. (JLC) |
Filing 3 Summons Issued as to Janssen Pharmaceuticals Inc, Johnson & Johnson Inc, Teva Branded Pharmaceutical Products R&D, Teva Pharmaceuticals USA Inc. Mailed certified mail. (MEB2) |
Filing 2 Request for service by certified mail filed by Beverly N Zekoff. (KEK) |
Filing 1 COMPLAINT against Janssen Pharmaceuticals Inc, Johnson & Johnson Inc, Teva Branded Pharmaceutical Products R&D, Teva Pharmaceuticals USA Inc, filed by Beverly N Zekoff.(KEK) |
Filing Fee: Filing fee $ 400, receipt_number 1126-3706590 (B4601109382). related document #1 COMPLAINT against Janssen Pharmaceuticals Inc, Johnson & Johnson Inc, Teva Branded Pharmaceutical Products R&D, Teva Pharmaceuticals USA Inc, filed by Beverly N Zekoff.(KEK). (Pantazis, Dennis) Modified on 10/30/2020 (MEB2). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Alabama Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.